CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $4.76B, above the global median of $1.15B
- PositionGross margin is 26.6%, lower than 95% of its Medical Instruments & Supplies peers (median 54%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.41%Below 5Y avg (1.65%)
Annual Rate
CNY 0.20Paid semi-annual
Payout Ratio
14.4%Sustainable
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
32.04BCNY4.76B · vs all stocks (USD)
Trailing P/E
46.82xvs Medical Instruments & Supplies peers
Revenue (TTM)
10.32BCNY1.53B · vs all stocks (USD)
Profit Margin
6.47%vs Medical Instruments & Supplies peers
Beta
0.0960xvs all stocks
52-Week Change
30.75%vs all stocks
Forward Annual Dividend Yield
0.41%vs all stocks
Market Capitalization
32.04BCNY4.76B · vs all stocks (USD)
Enterprise Value
29.83BCNY4.43B · vs all stocks (USD)
Trailing P/E
46.82xvs Medical Instruments & Supplies peers
Forward P/E
20.63xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.09xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.34xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.89xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
14.65xvs Medical Instruments & Supplies peers
Gross Margin
26.57%vs Medical Instruments & Supplies peers
Profit Margin
6.47%vs Medical Instruments & Supplies peers
Operating Margin
14.77%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.69%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
3.80%vs Medical Instruments & Supplies peers
Revenue (TTM)
10.32BCNY1.53B · vs all stocks (USD)
Revenue per Share (TTM)
17.06CNYUpdated Aug 20, 2026Quarterly Revenue Growth
15.80%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
2.54BCNY376.96M · vs all stocks (USD)
EBITDA (TTM)
1.34BCNY199.01M · vs all stocks (USD)
Net Income (TTM)
668.01MCNY99.21M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-97.20%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
1.77BCNY262.76M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-660.06MCNY-98.03M · vs all stocks (USD)
Forward Annual Dividend Rate
0.2000CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
0.41%vs all stocks
Trailing Annual Dividend Rate
0.1500CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.31%vs all stocks
5-Year Average Dividend Yield
1.65%vs all stocks
Payout Ratio
14.42%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
318.06MCNYFY2025 · Dec 31, 2025Revenue
9.93BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
7.53BCNYFY2025 · Dec 31, 2025Gross Profit
2.39BCNYFY2025 · Dec 31, 2025Operating Income
973.99MCNY144.66M · vs all stocks (USD)
Pre-tax Income
1.23BCNYFY2025 · Dec 31, 2025Income Tax Expense
182.55MCNYFY2025 · Dec 31, 2025Net Income
1.05BCNYFY2025 · Dec 31, 2025EBIT
1.60BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.27BCNYFY2025 · Dec 31, 2025Research & Development
404.38MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
340.34MCNYFY2025 · Dec 31, 2025Other Operating Expenses
97.30MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
367.93MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
369.15MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.58CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.57CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
639.68MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
639.68MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.05BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-36.49MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.34BCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.12BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.80BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.05BCNYFY2025 · Dec 31, 2025Other Non-cash Items
465.19MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
107.53MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-278.43MCNYFY2025 · Dec 31, 2025Capital Expenditures
-2.46BCNYFY2025 · Dec 31, 2025Purchase of Investments
-28.13BCNYFY2025 · Dec 31, 2025Sale of Investments
19.16BCNYFY2025 · Dec 31, 2025Other Investing Activity
-17.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-11.45BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
21.10BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-16.96BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-422.17MCNYFY2025 · Dec 31, 2025Other Financing Charges
4.66BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
8.38BCNYFY2025 · Dec 31, 2025Shares Outstanding
655.16MSharesUpdated Aug 20, 2026Float Shares
320.27MSharesUpdated Aug 20, 2026% Held by Insiders
35.72%vs all stocks
% Held by Institutions
17.92%vs all stocks
Total Cash (MRQ)
12.86BCNY1.91B · vs all stocks (USD)
Total Cash per Share (MRQ)
25.65CNYUpdated Aug 20, 2026Total Debt (MRQ)
17.64BCNY2.62B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.9501xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.8430xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
36.39CNYUpdated Aug 20, 2026Total Assets
40.09BCNY5.95B · vs all stocks (USD)
Total Current Assets
16.30BCNYFY2025 · Dec 31, 2025Total Liabilities
21.52BCNYFY2025 · Dec 31, 2025Total Non-current Assets
23.79BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.34BCNYFY2025 · Dec 31, 2025Total Current Liabilities
19.18BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
5.95BCNYFY2025 · Dec 31, 2025Other Short-term Investments
7.24BCNYFY2025 · Dec 31, 2025Accounts Receivable
1.36BCNYFY2025 · Dec 31, 2025Inventory
1.33BCNYFY2025 · Dec 31, 2025Accounts Payable
1.26BCNYFY2025 · Dec 31, 2025Short-term Debt
17.09BCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.52MCNYFY2025 · Dec 31, 2025Long-term Debt
409.29MCNYFY2025 · Dec 31, 2025Common Stock (Book)
654.75MCNYFY2025 · Dec 31, 2025Retained Earnings
16.44BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
18.57BCNY2.76B · vs all stocks (USD)
Treasury Stock
239.12MCNYFY2025 · Dec 31, 202552-Week Low
33.41CNYUpdated Aug 20, 202652-Week High
68.44CNYUpdated Aug 20, 202652-Week Change
30.75%vs all stocks
Beta
0.0960xvs all stocks
50-Day MA
45.49CNYUpdated Aug 20, 2026200-Day MA
46.37CNYUpdated Aug 20, 2026Avg 10-Day Volume
9.07MSharesUpdated Aug 20, 2026Avg 30-Day Volume
11.04MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
1.04CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 26.6%, lower than 95% of its Medical Instruments & Supplies peers (median 54%)Significant
Gross margin: 0.27Industry median: 0.54Industry P5: 0.28Peers compared: 35.00
Current ratio is 0.84×, lower than 95% of its Medical Instruments & Supplies peers (median 2.98×)Significant
Current ratio: 0.84Industry median: 2.98Industry P5: 1.32Peers compared: 35.00
Financial Health
Altman Z-Score 1.76: grey zoneSignificant
Altman Z-Score: 1.76
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $4.76B, above the global median of $1.15BNotable
Market cap (USD): 4,759,119,139.107Global Median: 1,146,734,693.424
Revenue is $1.53B, above the global median of $520.53MNotable
Revenue (USD): 1,532,566,102.958Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Western Superconducting Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Balkrishna Industries Limited
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Eeverdisplay Optronics (Shanghai) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sichuan Changhong Electric Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Yadea Group Holdings Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Xinfengming Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Kontoor Brands Inc.
Tier 1ProductionThroughput-Bound ConversionFlowAttention
Coway Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Godrej Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Guangdong Kingshine Electronic Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Restar Corp.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Argosy Research Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
PixArt Imaging Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth